Novogene Europe is pleased to announce the launch of its new Whole Plasmid Sequencing service, powered by Oxford Nanopore Technologies ...
("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the ...
Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...
People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...
When pathogens enter our cells as part of an infection, our body will trigger a programmed cell death known as "pyroptosis" ...
Nucelion Therapeutics Pvt Ltd, a wholly owned subsidiary of Bharat Biotech International Ltd, established a Contract Research Development and Manufacturing Organisation (CRDMO) focused on cell and ...
In the largest genetic analysis of polycystic ovary syndrome to date, scientists have identified new variants linked to the ...
Growing investments in mRNA vaccine and therapeutic platforms, along with regulatory acceleration, are fueling steady global demand for high-purity raw materials.Austin, Nov. 04, 2025 (GLOBE NEWSWIRE) ...
Investor event in New York City to provide update on pivotal Phase 3 study of IMNN-001; offering in-person or virtual attendance on November 10, ...
1d
How new advances in 3D bioprinting, organoids and organs on-a-chip aid in the fight against cancer
Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.
Hyderabad: Vaccine maker Bharat Biotech is foraying into the contract research development and manufacturing organisation (CRDMO) space with the setti.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback